Ladenburg Thalmann Downgrades United Therapeutics Corp. (UTHR) to Neutral - StreetInsider.com

Breaking Finance News
Ladenburg Thalmann Downgrades United Therapeutics Corp. (UTHR) to Neutral
StreetInsider.com
Ladenburg Thalmann downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Buy to Neutral with a price target of $145.00 (from $138.00). Analyst Matt Kaplan comments "We continue to find the Q/Q lackluster growth in Orenitram revenue
United Therapeutics Corporation (UTHR) is Downgraded by Ladenburg ...Highland Mirror
United Therapeutics Co. (UTHR) Downgraded to “Neutral&rdquo